Mylan (MYL) Snaps Up Swedish Drugmaker Meda AB (MEDA-A.ST) in $7.2 Billion Deal
Top Four California Life Science Job Regions
Investors And Scientists Question Whether Brent Saunders Will "Get Religion" And Support Pfizer (PFE)'s Internal R&D
Former Google (GOOG) Exec to Take Helm at San Francisco Diagnostic Firm Grail
Armed with $50 Million from Google (GOOG), Celgene (CELG) and More, ARMO BioSciences Eyes Next-Gen Cancer Drug Combos
Startup Yumanity Closes on $45 Million, With Biogen (BIIB) and Sanofi-Genzyme BioVentures Joining In
Hikma (HIK.L) Halves Cash Offer for Boehringer Ingelheim's Roxane, Will Pay $575 Million Less
Ex-Salix (SLXP) CEO, CFO Investigated for Misleading Investors About Drug Inventory Levels
Patient Deaths Push the FDA to Slap Full Clinical Hold on CTI BioPharma's Cancer Drug Pacritinib
Chugai Pharma's Alecensa Trial Stopped Early After Successfully Meeting Primary Endpoint
FDA Lifts Heat Biologics Partial Clinical Hold
AbbVie (ABBV)'s Elagolix Successful in Second Phase III Study
Comments by Principal Investigator the Real Reason NW Bio (NWBO)'s Stock Tanked Last Fall
Three Biotech Stocks to Buy When the Market Crashes
Ex-FDA Head Accused of Conspiring to Suppress Information About Harmful Effects of Johnson & Johnson (JNJ) Antibiotic
Juno (JUNO) Awards CEO and CFO Special Bonuses After Inking $1 Billion Celgene (CELG) Deal
Pfizer (PFE) Announces Merger Structure and Top Executive Team
Eli Lilly (LLY) Takes Part in Secretive Program with Tech Giant Apple (AAPL), Buys 15,000 iPads for Workers in Field
See All News >
Ex-FDA Head Accused of Conspiring to Suppress Information About Harmful Effects of Johnson & Johnson (JNJ) Antibiotic
Juno (JUNO) Awards CEO and CFO Special Bonuses After Inking $1 Billion Celgene (CELG) Deal
Pfizer (PFE) Announces Merger Structure and Top Executive Team
Eli Lilly (LLY) Takes Part in Secretive Program with Tech Giant Apple (AAPL), Buys 15,000 iPads for Workers in Field
Tennessee Oncology Sues Genentech (RHHBY) Over Cancer Drug Herceptin
Orphan Drug Company Horizon Pharma (HZNP) Projects $1 Billion+ Sales for 2016, to Double Jobs by 2020
Three Drugs Could Catapult Three Big Pharma Revenues This Year
AstraZeneca PLC (AZN)'s Immunotherapy Lung Cancer Combo Treatment Sees Breakthrough in Early Stage Trial
SoCal's Amplyx Ups Series B Financing to $49.2 Million and Beefs Up Executive Team
The Science Of Why Your Muscles Get Less Sore As You Stick With Your Gym Routine, Brigham Young University Study
Why Celgene (CELG) and Gilead (GILD) Stock Can Jump 30% This Year
Four Big Dividend Pharma Stocks to Buy that are Cheap Now
Johnson & Johnson (JNJ) Falls as FDA Staffers Back Celltrion (068270.KQ)'s Remicade Biosimilar
Biogen (BIIB) Points Out Three New Risk Factors For 2016 in SEC Filing, Report Shows
Nanoparticle Therapy That Uses LDL And Fish Oil Kills Liver Cancer Cells, UT Southwestern Medical Center Study
FDA Slaps Partial Clinical Hold on CTI BioPharma's Lead Product Candidate Pacritinib, Stock Crumbles
FDA Delays Decision on Sarepta (SRPT)'s Muscle-Wasting Disorder Drug
Inside The Cloning Factory That Creates 500 New Animals A Day, Sooam Biotech Reveals
See All News >
//-->